Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1480-1481, 2005-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
IV vancomycin to oral linezolid switch potentially cost saving
Inpharma, Vol. 1, Iss. 1400, 2003-01 ,pp. :
Access to resources
Recommend
IV vancomycin to oral linezolid switch potentially cost saving
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 425, 2003-01 ,pp. :
Guideline switch from ondansetron to granisetron cost saving
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 302, 2001-01 ,pp. :
Guideline switch from ondansetron to granisetron cost saving
Inpharma, Vol. 1, Iss. 1277, 2001-01 ,pp. :
Moxifloxacin IV-to-oral switch proves cost effective in patients with CAP
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 368, 2002-01 ,pp. :